Aurobindo gets USFDA nod for generic anti-herpes tablets

01 Feb 2011 Evaluate

Aurobindo Pharma has received tentative approval from the US health regulator to manufacture and market generic Famciclovir tablets for the treatment of herpes virus infections.

The approval was granted by the United States Food and Drug Administration (USFDA) for Famciclovir tablets in the strengths of 125 mg, 250 mg and 500 mg,
Famciclovir tablets are the generic versions of Novartis Pharmaceuticals’ Famvir tablets, which are sold in the strengths of 125 mg, 250 mg and 500 mg. The product has a market size of approximately $170 million for the 12 months ending September 30, 2010, according to the IMS.

Aurobindo Pharma Share Price

1215.35 -8.30 (-0.68%)
05-Dec-2025 15:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×